Share this Article
Liang R, Wang Z, Chen XQ, Bai QX
Correspondence: Prof Rong Liang, rongliang1017@gmail.com
ABSTRACT
We herein report the case of a 50-year-old woman who presented with persistent fever and a large mass in her right breast. Haematology, liver function, and other blood test results were abnormal. Computed tomography and positron emission tomography indicated that the lesion had spread to multiple organs. Immunohistochemical staining confirmed that the patient had plasmablastic lymphoma, an invasive and rare form of diffuse large B-cell lymphoma, and an underlying infection by the Epstein-Barr virus. After three rounds of CHOPE chemotherapy, followed by hyperCVAD and ESHAP, the patient achieved rapid and complete remission. This case is unusual in that the patient presented with a large breast mass and her recovery was extremely rapid.
Keywords: chemotherapy, CHOPE, clinicopathology, diffuse large B-cell lymphoma, plasmablastic lymphoma
Singapore Med J 2014; 55(12): e194-e197; http://dx.doi.org/10.11622/smedj.2014184
REFERENCES
| 1. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas in the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89:1413-20. PMid:9028965 | ||||
| 2. Castillo JJ, Reagan JL. Plasmablastic lymphoma: a systematic review. ScientificWorldJournal 2011; 11:687-96. http://dx.doi.org/10.1100/tsw.2011.59 | ||||
| 3. Stein H, Harris N, Campo E. Plasmablastic lymphoma. In: Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, Thile J, Vardiman J, eds. WHO classification of tumours of the haematopoietic and lymphoid tissues. Lyon France: IARC, 2008:256?57. | ||||
| 4. Castillo JJ, Winer ES, Stachurski D, et al. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma 2010; 51:2047-53. http://dx.doi.org/10.3109/10428194.2010.516040 | ||||
| 5. Tavora F, Gonzalez-Cuyar LF, Sun CC, Burke A, Zhao XF. Extra-oral plamablastic lymphoma: report of a case and review of literature. Hum Pathol 2006; 37:1233-6. http://dx.doi.org/10.1016/j.humpath.2006.04.009 | ||||
| 6. Mansoor M, Alani FS, Aslam MB, et al. A case report of cecal plasmablastic lymphoma in a HIV-negative patient. Eur J Gastroenterol Hepatol 2012; 24:332-5. http://dx.doi.org/10.1097/MEG.0b013e32834eb8d0 | ||||
| 7. Wang J, Hermandez OJ, Sen F. Plasmablastic lymphoma involving breast: a case diagnosed by fine-needle aspiration and core needle biopsy. Diagn Cytopathol 2008; 36:257-61. http://dx.doi.org/10.1002/dc.20784 | ||||
| 8. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971; 31:1860-1. PMid:5121694 | ||||
| 9. Castillo JJ, Furman M, Beltrán BE, et al. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer 2012; 118:5270-7. http://dx.doi.org/10.1002/cncr.27551 | ||||
| 10. Liu JJ, Zhang L, Ayala E, et al. Human immunodeficiency virus (HIV)-negative plasmablstic lymphoma: a single institutional experience and literature review. Leuk Res 2011; 35:1571-7. http://dx.doi.org/10.1016/j.leukres.2011.06.023 | ||||
| 11. Bibas M, Grisetti S, Alba L, et al. Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. J Clin Oncol 2010; 28:e704-8. http://dx.doi.org/10.1200/JCO.2010.30.0038 | ||||
| 12. Liang R, Chen XQ, Bai QX, et al. Successful treatment of refractory mantle cell lymphoma with PAD regimen: a case report. Chin J Cancer Prev Treat 2011; 18:968-9. | ||||
| 13. Law MF, Poon WL, Ng KS, et al. Quantification of plasma Epstein-Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma. Ann Hematol 2012; 91:789-91. http://dx.doi.org/10.1007/s00277-011-1313-1 | ||||